研究成果
年分
作者
期刊
研究名稱
2023
Bautista JAL, Lin CY*, Lu CT, Lo LW, Lin YJ, Chang SL, Hu YF, Chung FP, Tuan TC, Chao TF, Liao JN, Chang TY, Kuo L, Liu CM, Liu SH, Wu C, Kuo MJ, Li GY, Huang YS, Wu SJ, Siow YK, Son NND, Tran DC, Chen SA.
Front Cardiovasc Med 2023;10:1265890. (IF:3.6)
Clinical significance of substrate characteristics and ablation outcomes in patients with atrial fibrillation and significant functional mitral regurgitation.
2023
Bucci T, Shantsila A, Romiti GF, Teo WS, Park HW, Shimizu W, Mei DA, Tse HF, Proietti M, Chao TF*, Lip GYH*.
Sci Rep 2023;13(1):18375. (IF:4.6)
Sex-related differences in presentation, treatment, and outcomes of Asian patients with atrial fibrillation: a report from the prospective APHRS-AF Registry.
2023
Chan CS, Lin FJ, Chen YC, Lin YK, Higa S, Chen SA, Chen YJ*.
Int J Mol Sci 2023;24(17):13100. (IF:5.6)
Glucagon-like Peptide-1 Receptor Activation Reduces Pulmonary Vein Arrhythmogenesis and Regulates Calcium Homeostasis.
2023
Chan YH, Chan CY, Chen SW, Chao TF*, Lip GYH.
Europace 2023;25(10):euad288. (IF:6.1)
Comparisons of effectiveness and safety between on-label dosing, off-label underdosing, and off-label overdosing in Asian and non-Asian atrial fibrillation patients treated with rivaroxaban: a systematic review and meta-analysis of observational studies.
2023
Chan YH*, Chao TF, Chen SW, Kao YW, Huang CY, Chu PH.
Clin J Am Soc Nephrol 2023;18(7):858-868. (IF:9.8)
The Association of Background Medications on Initial eGFR Change and Kidney Outcomes in Diabetic Patients Receiving SGLT2 Inhibitor.
2023
Chan YH*, Chao TF, Chen SW, Kao YW, Huang CY, Chu PH*.
Eur Heart J-Qual Care Clin Outcomes 2023;9(4):397-407. (IF:5.2)
Association of acute increases in serum creatinine with subsequent outcomes in patients with type 2 diabetes mellitus treated with sodium-glucose cotransporter 2 inhibitor or dipeptidyl peptidase-4 inhibitor.
2023
Chang HC, Cheng HM, Kuo L, Lee DY, Sung SH, Chen CH, Yu WC*.
J Chin Med Assoc 2023;86(1):19-25. (IF:3)
Risk stratification in patients with hypertrophic cardiomyopathy: Looking beyond the left side myocardial function.
2023
Chang HC, Kuo L, Sung SH, Weng CY, Chen CK, Niu DM, Chen SA, Yu WC*.
J Am Heart Assoc 2023;12(1):e027041. (IF:5.4)
Left Ventricular Apical Aneurysm in Fabry Disease: Implications for Clinical Significance and Risk Stratification.
2023
Chang LH, Chu CH, Huang CC, Lin LY*.
Ther Adv Endocrinol Metab 2023;14:20420188231207345. (IF:3.8)
Soluble tumor necrosis factor receptor type 1 predicts cardiorenal outcomes and better associated with distinct cardiovascular or renal outcomes than precedential renal or cardiovascular events in type 2 diabetes mellitus.
2023
Chang TT*, Li SY, Lin LY, Chen C, Chen JW*.
Biomed Pharmacother 2023;161:114450. (IF:7.5)
Macrophage inflammatory protein-1? as a novel therapeutic target for renal protection in diabetic kidney disease.